Clin2
NCT06626386Likely a fitRecruiting

Prostate cancer screening with a finger-prick test

Prostate Cancer

Part of Cancer, Kidney & urinary clinical trials.

This trial is testing a simple finger-prick blood test to measure prostate-specific antigen (PSA) for prostate cancer screening. It aims to make screening easier and more accessible.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
45 years to 70 years
Study type
Observational

Who can take part

  • You are a man between 45 and 70 years old.
  • You agree to have your PSA level tested for prostate cancer screening.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07454603Recruiting
Blood test for prostate cancer risk

This trial tests a new blood test to help decide if you need a prostate biopsy. It may help men with high PSA levels or an abnormal rectal exam avoid unnecessary procedures.

Branford, Connecticut
NCT03423303Enrolling by invitation
Screening test to find early prostate cancer sooner

This trial checks whether an early prostate cancer screening approach can detect clinically significant prostate cancer sooner. It may help participants catch the disease at an earlier stage when treatment can be more effective.

Helsinki
NCT03914391Recruiting
Find new urine tests to screen for prostate cancer

This study looks for new urine markers (signals) that could help screen for prostate cancer. If you have a higher PSA blood test and are scheduled for a prostate biopsy, your urine sample may be studied to see if it can improve screening.

Shatin
NCT06604130Enrolling by invitation
Prostate cancer diagnosis using blood exosomes

This study explores whether a simple blood test that looks at tiny particles called exosomes can help diagnose prostate cancer, possibly reducing the need for biopsies. If you have higher PSA levels and are scheduled for a biopsy, this trial might be a fit.

Lanzhou, Gansu
NCT06917781Recruiting
Prostate cancer blood test vs. PSMA-PET scan study

This study is checking how well a blood test (liquid biopsy) can find prostate cancer and compare it to a special PET scan (PSMA-PET). If you qualify, you might help improve how we track prostate cancer without needing more invasive biopsies.

Toulouse
NCT06424275Enrolling by invitation
Prostate cancer screening trial for European men ages 50-69

This trial aims to raise awareness and screen for prostate cancer in men aged 50 to 69 across the European Union. You may be able to join if you have never been diagnosed with prostate cancer and haven't had a prostate biopsy or MRI in the last six months.

Dublin

Hear when a new Prostate cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.